These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18609104)

  • 1. Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test.
    Stejskal D; Karpísek M; Hanulová Z; Stejskal P
    Scand J Clin Lab Invest; 2008; 68(6):501-7. PubMed ID: 18609104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Karpísek M; Reutová H; Humenanská V; Petzel M; Kusnierová P; Vareka I; Vareková R; Stejskal P
    Gen Physiol Biophys; 2008 Mar; 27(1):59-63. PubMed ID: 18436985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like protein 3: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Karpísek M; Humenanská V; Solichová P; Stejskal P
    Gen Physiol Biophys; 2007 Sep; 26(3):230-3. PubMed ID: 18063851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Karpísek M; Humenanska V; Hanulova Z; Stejskal P; Kusnierova P; Petzel M
    Horm Metab Res; 2008 Jun; 40(6):381-5. PubMed ID: 18393169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome.
    Barutcuoglu B; Basol G; Cakir Y; Cetinkalp S; Parildar Z; Kabaroglu C; Ozmen D; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2011; 41(4):390-6. PubMed ID: 22166511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA.
    Stejskal D; Karpísek M; Reutová H; Stejskal P; Kotolová H; Kollár P
    Clin Biochem; 2008 Mar; 41(4-5):313-6. PubMed ID: 18078816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proguanylin: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Solichova P; Lacnak B; Vaclavik J; Hanulova Z; Humenanska V; Sprongl L; Karpisek M
    Gen Physiol Biophys; 2007 Mar; 26(1):62-5. PubMed ID: 17579256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults.
    Puchau B; Zulet MA; González de Echávarri A; Navarro-Blasco I; Martínez JA
    Eur J Clin Nutr; 2009 Jul; 63(7):858-64. PubMed ID: 18985060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
    Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
    Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
    Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
    Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays.
    Durham BH; Joseph F; Bailey LM; Fraser WD
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):463-6. PubMed ID: 17761032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
    Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
    J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
    Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword.
    Park W; Kim BS; Lee JE; Huh JK; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR; Rhee EJ; Oh KW; Lee WY; Park CY; Park SW; Kim SW
    Diabetes Res Clin Pract; 2009 Jan; 83(1):119-25. PubMed ID: 19101054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.
    Ebrahimi A; Nabipour I; Vahdat K; Jafari SM; Fouladvand M; Assadi M; Movahed A; Obeidi N; Sanjdideh Z
    Diabetes Res Clin Pract; 2009 Jun; 84(3):296-302. PubMed ID: 19362745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes.
    Matuszek B; Lenart-Lipińska M; Duma D; Solski J; Nowakowski A
    Endokrynol Pol; 2010; 61(1):50-4. PubMed ID: 20205104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity].
    Yan WJ; Wu J; Mo J; Huang CW; Peng LW; Xu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):47-50. PubMed ID: 19149923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.